Literature DB >> 12951577

Therapeutic antagonists and conformational regulation of integrin function.

Motomu Shimaoka1, Timothy A Springer.   

Abstract

Integrins are a structurally elaborate family of adhesion molecules that transmit signals bi-directionally across the plasma membrane by undergoing large-scale structural rearrangements. By regulating cell-cell and cell-matrix contacts, integrins participate in a wide range of biological processes, including development, tissue repair, angiogenesis, inflammation and haemostasis. From a therapeutic standpoint, integrins are probably the most important class of cell-adhesion receptors. Recent progress in the development of integrin antagonists has resulted in their clinical application and has shed new light on integrin biology. On the basis of their mechanism of action, small-molecule integrin antagonists fall into three different classes. Each of these classes affect the equilibria that relate integrin conformational states, but in different ways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951577     DOI: 10.1038/nrd1174

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  106 in total

1.  Identification of integrin beta subunit mutations that alter heterodimer function in situ.

Authors:  Alison L Jannuzi; Thomas A Bunch; Robert F West; Danny L Brower
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

Review 2.  Positioning the immune system: unexpected roles for alpha6-integrins.

Authors:  Gillian Borland; William Cushley
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

3.  Novel activating and inactivating mutations in the integrin beta1 subunit A domain.

Authors:  Stephanie J Barton; Mark A Travis; Janet A Askari; Patrick A Buckley; Susan E Craig; Martin J Humphries; A Paul Mould
Journal:  Biochem J       Date:  2004-06-01       Impact factor: 3.857

4.  The C-terminal αI domain linker as a critical structural element in the conformational activation of αI integrins.

Authors:  Gabriele Weitz-Schmidt; Thomas Schürpf; Timothy A Springer
Journal:  J Biol Chem       Date:  2011-09-30       Impact factor: 5.157

5.  Discovery of very late antigen-4 (VLA-4, alpha4beta1 integrin) allosteric antagonists.

Authors:  Alexandre Chigaev; Yang Wu; D Bart Williams; Yelena Smagley; Larry A Sklar
Journal:  J Biol Chem       Date:  2010-12-03       Impact factor: 5.157

Review 6.  Integrins as therapeutic targets: lessons and opportunities.

Authors:  Dermot Cox; Marian Brennan; Niamh Moran
Journal:  Nat Rev Drug Discov       Date:  2010-10       Impact factor: 84.694

7.  Isoflurane inhibits neutrophil recruitment in the cutaneous Arthus reaction model.

Authors:  Carla Carbo; Koichi Yuki; Melanie Demers; Denisa D Wagner; Motomu Shimaoka
Journal:  J Anesth       Date:  2012-10-25       Impact factor: 2.078

Review 8.  Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Authors:  Johannes A Eble; Flávia Figueiredo de Rezende
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

9.  Small-molecule inhibitors of integrin alpha2beta1 that prevent pathological thrombus formation via an allosteric mechanism.

Authors:  Meredith W Miller; Sandeep Basra; Daniel W Kulp; Paul C Billings; Sungwook Choi; Mary Pat Beavers; Owen J T McCarty; Zhiying Zou; Mark L Kahn; Joel S Bennett; William F DeGrado
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-13       Impact factor: 11.205

10.  Interactions of foot-and-mouth disease virus with soluble bovine alphaVbeta3 and alphaVbeta6 integrins.

Authors:  Hernando Duque; Michael LaRocco; William T Golde; Barry Baxt
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.